- Home
- AVIR vs AOMR Comparison
AVIR vs AOMR Comparison
Compare AVIR & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | AOMR |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.7M | 224.3M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AVIR | AOMR |
|---|---|---|
| Price | $3.18 | $8.86 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $6.00 | ★ $11.13 |
| AVG Volume (30 Days) | ★ 415.4K | 132.3K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 14.51% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.73 |
| Revenue | N/A | ★ $34,705,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.56 |
| P/E Ratio | ★ N/A | $12.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.46 | $7.36 |
| 52 Week High | $4.02 | $10.88 |
Technical Indicators
Market Signals| Indicator | AVIR | AOMR |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 51.27 |
| Support Level | $2.99 | $8.67 |
| Resistance Level | $3.24 | $8.93 |
| Average True Range (ATR) | 0.09 | 0.15 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 79.03 | 86.82 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.